Copper Curcuminoids Containing Anthracene Groups: Fluorescent Molecules with Cytotoxic Activity
- 14 September 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 49 (20) , 9655-9663
Abstract
The coordination chemistry of the new curcuminoid ligand, 1,7-(di-9-anthracene-1,6-heptadiene-3,5-dione), abbreviated 9Accm has been studied, resulting in two new copper-9Accm compounds. Compound 1, [Cu(phen)Cl(9Accm)], was synthesized by reacting 9Accm with [Cu(phen)Cl2] in a 1:1 ratio (M:L) and compound 2, [Cu(9Accm)2], was prepared from Cu(OAc)2 and 9Accm (1:2). UV−vis, electron paramagnetic resonance (EPR), and superconducting quantum interference device (SQUID) measurements were some of the techniques employed to portray these species; studies on single crystals of free 9Accm, [Cu(phen)Cl(9Accm)] and [Cu(9Accm)2(py)] provided detailed structural information about compounds 1 and 2·py, being the first two copper-curcuminoids crystallographically described. In addition the antitumor activity of the new compounds was studied and compared with free 9Accm for a number of human tumor cells. To provide more insight on the mode of action of these compounds under biological conditions, additional experiments were accomplished, including studies on the nature of their interactions with calf thymus DNA by UV−vis titration and Circular Dichroism. These experiments together with DNA-binding studies indicate electrostatic interactions between some of these species and the double helix, pointing out the weak nature of the interaction of the compounds with CT-DNA. The intrinsic fluorescence of the free ligand and both copper compounds provided valuable information over the cellular process and therefore, fluorescence microscopy studies were performed using a human osteosarcoma cell line. Studies in vitro using this technique suggest that the action of these molecules seems to occur outside the nuclei.Keywords
This publication has 59 references indexed in Scilit:
- RETRACTED: Apoptotic cell death: A possible key event in mediating the in vitro anti-proliferative effect of a novel copper(II) complex, [Cu(4-Mecdoa)(phen)2] (phen = phenanthroline, 4-Mecdoa = 4-methylcoumarin-6,7-dioxactetate), in human malignant cancer cellsEuropean Journal of Pharmacology, 2007
- Copper-1,10-Phenanthroline-Induced Apoptosis in Liver Carcinoma Bel-7402 Cells Associates with Copper Overload, Reactive Oxygen Species Production, Glutathione Depletion and Oxidative DNA DamageBioMetals, 2006
- DNA Oxidation by Copper and Manganese Complexes2006
- Orally active antioxidative copper(II) aspirinate: synthesis, structure characterization, superoxide scavenging activity, and in vitro and in vivo antioxidative evaluationsJBIC Journal of Biological Inorganic Chemistry, 2005
- In vivo anticancer, anti-inflammatory, and toxicity studies of mixed-ligand Cu(II) complexes of dien and its Schiff dibases with heterocyclic aldehydes and 2-amino-2-thiazoline. Crystal structure of [Cu(dien)(Br)(2a-2tzn)](Br)(H2O)Journal of Inorganic Biochemistry, 2005
- Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cellsBiochemical Pharmacology, 2004
- Through metal binding, curcumin protects against lead- and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brainJournal of Inorganic Biochemistry, 2004
- Nuclease activity of 1,10-phenanthroline-copper: kinetic mechanismJournal of the American Chemical Society, 1989
- Sequence specificity of DNA cleavage by bis(1,10-phenanthroline)copper(I)Biochemistry, 1988
- Cleavage of DNA by the 1,10-phenanthroline-copper ion complex. Superoxide mediates the reaction dependent on NADH and hydrogen peroxideJournal of the American Chemical Society, 1981